(0.03%) 5 471.13 points
(0.00%) 39 113 points
(0.35%) 17 779 points
(-0.47%) $80.45
(-4.50%) $2.63
(-0.85%) $2 311.00
(0.02%) $28.88
(2.29%) $1 009.00
(0.27%) $0.936
(0.62%) $10.67
(0.45%) $0.792
(-0.29%) $87.24
Live Chart Being Loaded With Signals
Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility...
Stats | |
---|---|
Today's Volume | 56 008 |
Average Volume | 42 487 |
Market Cap | 79.74M |
EPS | $-0.0484 ( Q1 | 2024-05-02 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-36.00 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0200 (1.85%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-11 | Farley Chele Chiavacci | Buy | 37 272 | Common Stock |
2024-06-11 | Bligh James | Buy | 37 272 | Common Stock |
2024-05-15 | Sragovicz Adam | Sell | 74 545 | Restricted Stock Units |
2024-05-13 | Mcnealey Jennifer Isacoff | Sell | 65 000 | Stock Option (Right to Buy) |
2024-04-22 | Tapolczay David | Buy | 400 664 | Warrant (Right to buy) |
INSIDER POWER |
---|
85.51 |
Last 70 transactions |
Buy: 7 479 034 | Sell: 1 520 397 |
Volume Correlation
Conduit Pharmaceuticals Correlation
10 Most Positive Correlations | |
---|---|
OZEM | 1 |
ALNT | 0.885 |
FSVLX | 0.88 |
AVEAX | 0.855 |
GDMOX | 0.853 |
MAPPX | 0.841 |
KCOPX | 0.841 |
MPAIX | 0.84 |
INBS | 0.837 |
AAME | 0.832 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Conduit Pharmaceuticals Correlation - Currency/Commodity
Conduit Pharmaceuticals Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.00800 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.00800 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.280 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Conduit Pharmaceuticals
Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It\'s pipeline includes AZD1656 for the treatment of hashimoto\'s thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators